Background Targeted human papillomavirus (HPV) vaccine could prevent HPV-related
cancers and genital warts among men who have sex with men (MSM). In order to develop …

Objectives If approved for use in young males in the United States, prophylactic human
papillomavirus (HPV) vaccine may reduce the incidence of HPV-related disease in …

Background: For human papillomavirus (HPV) vaccination to have maximum benefit to
public health, both men and women should be vaccinated. Although efficacy trials in men …

Background Men who have sex with men (MSM) are recommended the Human
Papillomavirus (HPV) vaccination due to their higher risk of genital warts and anal cancer …

Background Men who have sex with men (MSM) are disproportionately affected by human
papillomavirus (HPV)–related outcomes and would benefit from HPV vaccination in …

This study aimed to ascertain the attitudes of men who have sex with men (MSM) to the
human papillomavirus (HPV) vaccine and to determine the age at which MSM would be …

Objective To understand rates of human papillomavirus (HPV) vaccine acceptability and
factors correlated with HPV vaccine acceptability. Design Meta-analyses of cross-sectional …

Men who have sex with men (MSM) are at high risk of contracting HIV and developing
genital warts and penile/anal cancers. HPV vaccines are efficacious in preventing such HPV …

Background Human papillomavirus (HPV) is a common sexually transmitted infection that
causes anal, penile, and oropharyngeal cancers in men. Men who have sex with men …

Objectives: To investigate the acceptability of human papillomavirus (HPV) vaccination
among men who have sex with men (MSM) and its associated factors. Methods: We …